Vincent Weynants

This inventor holds 10 USPTO granted patents and 13 published patent applications and 9 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Glaxosmithkline Intellectual Property Development Limited, Utrecht University. Active years: 2010-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vincent Weynants. Retrieved from https://idiyas.com/inventor/vincent-weynants

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 13)

% Patents Active = 50.0

EPO Patents = 9 (Patent Applications = 18)

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

Rixensart, BE (2010 - 2017)
Wavre, BE (2021 - 2023)

Company Filing History:

10 out of 545

Glaxosmithkline Biologicals Sa

patents

1 out of 242

Glaxosmithkline Intellectual Property Development Limited

where one patent can have more than one assignee

Years Active: 2010-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11723966 - Methods of boosting immune responses (2023-08-15),

2. 11167022 - Immunogenic composition, use and method of treatment (2021-11-09),

3. 9567377 - Immunogenic composition (2017-02-14),

4. 9365624 - Vaccine (2016-06-14),

5. 9259461 - [object Object] (2016-02-16),

6. 9023606 - Vaccine protection assay (2015-05-05),

7. 8679770 - [object Object] (2014-03-25),

8. 8221770 - Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis (2012-07-17),

9. 7955817 - Vaccine protection assay (2011-06-07),

10. 7838014 - [object Object] (2010-11-23),

Title: Biography of Vincent Weynants

Introduction

Vincent Weynants is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of immunology, particularly in the development of vaccines and treatments for chronic obstructive pulmonary disease (COPD). With a total of 10 patents to his name, Weynants has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents, Weynants has developed methods of boosting immune responses through immunogenic compositions. These compositions include immunogenic polypeptides that are utilized in treating and preventing exacerbations of chronic obstructive pulmonary disease. Another significant patent involves immunogenic compositions aimed at preventing acute exacerbations of COPD resulting from bacterial infections.

Career Highlights

Weynants has had a distinguished career, working with prominent organizations such as GlaxoSmithKline Biologicals and Utrecht University. His work has focused on advancing medical treatments and enhancing immune responses, contributing to better health outcomes for patients suffering from respiratory diseases.

Collaborations

Throughout his career, Weynants has collaborated with esteemed colleagues, including Jan Poolman and Isabel De Vleeschauwer. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Vincent Weynants continues to be a driving force in the field of immunology. His inventions

Profile summary based on public USPTO records.